Published in Acad Psychiatry on June 01, 1997
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci (1984) 4.52
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization. Neuroscience (1983) 3.09
The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci (1984) 2.99
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
Health and disability costs of depressive illness in a major U.S. corporation. Am J Psychiatry (2000) 1.64
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A (1996) 1.49
Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res (1975) 1.40
Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.39
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci (1997) 1.33
Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. Science (1980) 1.28
Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J Neurosci (2000) 1.28
Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci (1983) 1.26
Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci (1976) 1.25
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--2. Action potential generating mechanisms and morphological correlates. Neuroscience (1983) 1.23
Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience (1984) 1.22
Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol (1974) 1.21
Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience (1999) 1.21
Beginning careers in academic psychiatry for women--"Bermuda Triangle"? Am J Psychiatry (1993) 1.21
Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science (1979) 1.19
Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther (1986) 1.19
Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neurochem (1989) 1.18
Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res (1985) 1.17
Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci (1978) 1.17
Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur J Pharmacol (1979) 1.16
Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem (1990) 1.15
Normative implications of the relationship between reading vocabulary and Boston Naming Test performance. Arch Clin Neuropsychol (1993) 1.15
Repetitive firing properties of putative dopamine-containing neurons in vitro: regulation by an apamin-sensitive Ca(2+)-activated K+ conductance. Exp Brain Res (1991) 1.14
Firing properties of substantia nigra dopaminergic neurons in freely moving rats. Life Sci (1985) 1.13
A comparison of the structured clinical interview for DSM-III-R and clinical diagnoses. J Nerv Ment Dis (1995) 1.12
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--3. Evidence for electrotonic coupling. Neuroscience (1983) 1.11
Defining managed care in public-sector psychiatry. Hosp Community Psychiatry (1994) 1.08
Excitability properties of medial forebrain bundle axons of A9 and A10 dopamine cells. Brain Res (1988) 1.02
Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin. Brain Res (1987) 1.01
Effects of apamin on the discharge properties of putative dopamine-containing neurons in vitro. Brain Res (1988) 1.00
Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples. J Neuropsychiatry Clin Neurosci (1997) 0.98
Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. J Pharmacol Exp Ther (1989) 0.96
Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Brain Res (1985) 0.94
Applicants' choice of a residency training program. Am J Psychiatry (1987) 0.93
Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum. Neuroscience (1990) 0.93
Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci (1985) 0.92
Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophr Res (1991) 0.91
In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse (1993) 0.90
The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique. Brain Res (1976) 0.89
Affective reactivity of language in schizophrenia. J Nerv Ment Dis (1994) 0.88
Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse (1989) 0.87
Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity. Brain Res (1991) 0.87
Teaching about the doctor-patient relationship in the first postgraduate year. J Med Educ (1987) 0.87
Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J Neurosci (1992) 0.86
Nonlinear sequence-dependent structure of nigral dopamine neuron interspike interval firing patterns. Biophys J (1995) 0.86
Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors. Synapse (2000) 0.85
Services for mentally ill homeless persons: street-level integration. Am J Orthopsychiatry (1998) 0.85
The experiences of long-stay inpatients returning to the community. Psychiatry (1995) 0.84
d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway. Science (1976) 0.84
Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res (1990) 0.83
Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience (1981) 0.83
Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment. Neurosci Lett (1994) 0.83
The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol (1984) 0.83
Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine. Eur J Pharmacol (1988) 0.83
Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil. Synapse (2000) 0.82
Characterization of dopamine-induced depolarization of prefrontal cortical neurons. Synapse (1997) 0.82
Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. J Pharmacol Exp Ther (1981) 0.82
Actions of neurotensin: a review of the electrophysiological studies. Ann N Y Acad Sci (1992) 0.81
Working memory, attention, and communication disturbances in schizophrenia. J Abnorm Psychol (1996) 0.81
Pharmacological characterization of dopamine "autoreceptors" by microiontophoretic single-cell recording studies. Adv Biochem Psychopharmacol (1977) 0.81
Effect of sensory stimuli on the activity of dopaminergic neurons: involvement of non-dopaminergic nigral neurons and striato-nigral pathways. Life Sci (1980) 0.81
D1-D2 interaction in feedback control of midbrain dopamine neurons. J Neurosci (1997) 0.80
Effect of patient gender on evaluation of intern performance. Arch Intern Med (1989) 0.80
Neurotensin attenuates dopamine D2 agonist quinpirole-induced inhibition of midbrain dopamine neurons. Neuropharmacology (1990) 0.80
Anatomic basis of sequence-dependent predictability exhibited by nigral dopamine neuron firing patterns. Synapse (2001) 0.80
Differences in social environment between inpatient and day hospital-crisis respite settings. Psychiatr Serv (1996) 0.79
Antecedent psychological factors in the onset of vasovagal syncope. Psychosom Med (1978) 0.79
Depolarization inactivation of dopamine neurons: terminal release characteristics. Synapse (1993) 0.79
Effects of neurotensin on midbrain dopamine neurons: are they mediated by formation of a neurotensin-dopamine complex? Synapse (1991) 0.79
Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences. J Neurosci (1987) 0.79
Affective reactivity of language in stable schizophrenic outpatients and their parents. J Nerv Ment Dis (1994) 0.79
Effects of molindone on central dopaminergic neuronal activity and metabolism: similarity to other neuroleptics. Psychopharmacol Commun (1975) 0.79
Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.79
The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum. Mol Pharmacol (1988) 0.79
Four-year evaluation of a psychiatric clerkship: 1982-1986. Am J Psychiatry (1988) 0.78
Resident and faculty evaluations of a psychiatry night-float system. Acad Psychiatry (1996) 0.78
Effect of cholecystokinin of the activity of midbrain dopaminergic neurons. Adv Biochem Psychopharmacol (1982) 0.78
Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system. Science (1983) 0.78
D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons. Psychopharmacol Commun (1975) 0.78
Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation. Res Publ Assoc Res Nerv Ment Dis (1976) 0.78
Ritanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons. J Pharmacol Exp Ther (1995) 0.78
d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.77
Audiotape playback as a technique in the treatment of schizophrenic patients. Am J Psychiatry (1989) 0.77
Effects of lesions in the medial prefrontal cortex on the activity of midbrain dopamine neurons. Neuropsychopharmacology (1996) 0.77
5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse (1994) 0.77
The effect of acute and chronic treatment with SCH 23390 on the spontaneous activity of midbrain dopamine neurons. Eur J Pharmacol (1989) 0.77
A small volume chamber for electrical recording from submerged brain slices and a pulse-free medium supply system using a peristalic pump. J Neurosci Methods (1990) 0.77
Vasovagal syncope in aircrew. Psychosocial aspects. J Nerv Ment Dis (1979) 0.77
The effects of acute and chronic haloperidol treatment on spontaneously firing neurons in the caudate nucleus of the rat. Life Sci (1979) 0.77
Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity. Adv Neurol (1975) 0.76
Self-concept changes related to war captivity. Arch Gen Psychiatry (1980) 0.76
Dopaminergic blocking effects of antipsychotic drugs. J Psychiatr Res (1974) 0.76